Study on Post-acute Myocardial Infarction Ventricular Defect: Outcome Evalutation in Relation to Surgical Timing
Multicenter Study on Post-acute Myocardial Infarction Ventricular Defect: Outcome Evalutation in Relation to Surgical Timing
1 other identifier
observational
100
2 countries
4
Brief Summary
The main objective of the study is to identify the optimal surgical timing for the treatment of intraventricular defects after acute myocardial infarction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
Typical duration for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2024
CompletedFirst Submitted
Initial submission to the registry
November 28, 2024
CompletedFirst Posted
Study publicly available on registry
January 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
January 29, 2025
October 1, 2024
2.8 years
November 28, 2024
January 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Identify the optimal timing for the surgical intervention.
The optimal timing considering the time interval between the clinical-instrumental diagnosis and the surgical intervention
Possible timing for surgery can be: onset of the infarction episode, hospital admission, before seven days from the acute myocardial infarction or after seven days from the acute myocardial infarction.
Eligibility Criteria
Adult patients undergoing surgical repair of post-AMI ventricular septal defect between January 1, 2001 and December 31, 2021.
You may qualify if:
- Patients over eighteen years of age
- Patients with post-myocardial infarction ventricular septal defect treated surgically
- Patients who have signed the informed consent
You may not qualify if:
- Patients with post-infarction ventricular septal defect treated with medical/conservative therapy
- Patients with ventricular septal defects not due to acute myocardial infarction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, 40138, Italy
Ospedale Santa Maria della Misericordia Udine
Udine, Udine, 33100, Italy
Ospedale di Circolo e Fondazione Macchi Varese
Varese, Varese, 21010, Italy
Hospital Clinic Barcellona
Barcelona, Barcellona, 08024, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luca Di Marco, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2024
First Posted
January 29, 2025
Study Start
February 12, 2024
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
January 29, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share